Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

PARP inhibitors in cancer therapy: promise, progress, and puzzles.

Ellisen LW. PARP inhibitors in cancer therapy: promise, progress, and puzzles. Cancer Cell. 2011 Feb 15; 19(2):165-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.